XML 62 R51.htm IDEA: XBRL DOCUMENT v3.7.0.1
Common Stock (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 12, 2016
USD ($)
$ / shares
shares
Jun. 21, 2016
USD ($)
shares
May 17, 2016
USD ($)
$ / shares
shares
Apr. 22, 2016
USD ($)
shares
Apr. 29, 2015
$ / shares
shares
May 17, 2016
USD ($)
$ / shares
shares
Feb. 24, 2015
USD ($)
Nonexecutivedirectors
shares
Mar. 31, 2017
$ / shares
Dec. 31, 2015
USD ($)
shares
Dec. 31, 2016
shares
Apr. 28, 2016
shares
Mar. 17, 2016
shares
Feb. 09, 2015
shares
Jan. 01, 2015
shares
Dec. 31, 2014
$ / shares
Common Stock (Textual)                              
Share-based compensation expense | $ $ 517,018                            
Warrants outstanding to purchase         55,334,490                    
Class of warrant or right outstanding associated with anti-dilutive provision (in shares)         38,888,147                    
Reduced exercise price (in dollars per share) | $ / shares         $ 0.00005                    
Percentage of warrants receive common stock in exchange         17.50%                    
Extension term of warrants to waive anti-dilution rights         2 years                    
Warrants issued to purchase common stock (in shares)                           1,250,000  
Common stock, par value | $ / shares               $ 0.00005             $ 0.00005
Kahn Employment Agreement [Member]                              
Common Stock (Textual)                              
Share-based compensation expense | $     $ 180,824                        
Shares granted     6,067,931                        
Common stock diluted basis, description               Mr. Kahn was to receive an additional grant of fully-vested common stock, such additional grants each representing 0.75% of the Company's shares of common stock on a fully diluted basis as of May 1, 2017 and May 1, 2018, respectively. The Company expensed $23,268 in the year ended December 31, 2016 for the stock compensation grant related to the May 1, 2017 and May 1, 2018 additional grants. The Company will expense a portion of this compensation quarterly until the grants are made at their respective due dates.              
Common Stock [Member] | Alternative (1) [Member]                              
Common Stock (Textual)                              
Warrants issued to purchase common stock (in shares)                 52,110,896            
Loss on exchange of warrants | $                 $ 12,959,660            
Common Stock [Member] | Alternative (3) [Member]                              
Common Stock (Textual)                              
Warrants issued to purchase common stock (in shares)                 974,826            
Warrants [Member]                              
Common Stock (Textual)                              
Warrants issued to purchase common stock (in shares)                   50,957,780          
Warrant purchased aggregate price | $       $ 122,986                      
Number of warrants issued in initial closing offer to purchase common stock (in shares) 52,752,869                            
Shares of common stock issued during the period in exchange agreements 53,097,601                            
Common stock, par value | $ / shares $ 0.00005                            
Warrant purchased       4,610,179                      
Warrants [Member] | Alternative (2) [Member]                              
Common Stock (Textual)                              
Warrants issued to purchase common stock (in shares)                 318,750            
Warrants [Member] | Alternative (3) [Member]                              
Common Stock (Textual)                              
Warrants issued to purchase common stock (in shares)                 73,125            
Non-Executive Directors [Member]                              
Common Stock (Textual)                              
Share-based compensation expense | $             $ 150,000                
Shares issued for services (in shares)           3,020,134 576,924                
Common stock price per share | $ / shares     $ 0.0298     $ 0.0298                  
Number of non-executive directors | Nonexecutivedirectors             3                
Stock options vesting percentage           25.00%                  
Stock options vesting and expiration description          
These stock options vest 25% on date of grant and 25% every 90, 180 and 270 days subsequent to the grant date and expire ten years after the date of the grant.
                  
Brian Israel [Member]                              
Common Stock (Textual)                              
Shares issued for services (in shares)             192,308                
Morris Garfinkle [Member]                              
Common Stock (Textual)                              
Share-based compensation expense | $   $ 25,369             $ 3,749,259            
Warrants issued to purchase common stock (in shares) 6,023,022                     400,000 5,500,000    
Shares issued for services (in shares)   2,013,423       1,006,711 192,308                
Shares issued for services value | $           $ 30,000                  
Edward B. Smith III [Member]                              
Common Stock (Textual)                              
Warrants issued to purchase common stock (in shares) 31,868,774                       31,000,000    
Shares issued for services (in shares)           1,006,711                  
Shares issued for services value | $           $ 30,000                  
Dan Jeffery [Member]                              
Common Stock (Textual)                              
Warrants issued to purchase common stock (in shares) 1,600,000                   150,000 200,000      
Shares issued for services (in shares)           1,006,711 192,308                
Shares issued for services value | $           $ 30,000